|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated,advanced non-small cell lung cancer显示文摘Dear Editor,Nivolumab,an inhibitor of programmed cell death 1(PD-1),is an immune checkpoint inhibitor(ICI)that enhances T cell functions by preventing negative regulation of cancer immunity,and it has shown clinically significant efficacy and tolerability in various types of cancer.Based on the results of randomized phase III trials comparing nivolumab with docetaxel[1,2],nivolumab is now used in clinical practice for patients with previously treated advanced non-small cell lung cancer(NSCLC).Fur-thermore,the most recent Japan Lung Cancer Society guidelines include nivolumab monotherapy in the sys-temic treatment strategy for previously treated,locally advanced or metastatic NSCLC[3].However,ICIs induce characteristic immune-related adverse events(irAEs),which are not seen with conventional cytotoxic agents or molecular targeted agents.IrAEs can occur in any organ system,most typically the skin,lung,and gastrointesti-nal,hepatic,and endocrine systems. | Hideharu Kimura Tomoyuki Araya Taro Yoneda Hiroki Shirasaki Koji Kurokawa Tamami Sakai Hayato Koba Yuichi Tambo Shingo Nishikawa Takashi Sone Kazuo Kasahara | 2019 | Cancer Communications2019，39，1： | 3 |
| 2 | The Frequency of Type 2 CD8+ T Cells Is Increased in Peripheral Blood from Patients with Psoriasis Vulgaris显示文摘 | Makoto Inaoki Shinichi Sato Fumiaki Shirasaki Naofumi Mukaida Kazuhiko Takehara | 2003 | Journal of Clinical Immunology2003，，4： | 1 |
| 3 | Epstein-Barr virus-associated T-cell lymphoma: a case of eyelid swelling and intramuscular infihration mimicking dermatomyositis显示文摘 | Shirasaki F Taniuchi K Matsushita T | 2002 | Br J Dermatol2002，147，6： | 1 |
| 4 | Localization and upregulation of the nasal histamine hl receptor in peren-nial allergic rhinitis显示文摘 | Shirasaki H Kanaizumi E Seki N | 2012 | Mediators Inflamm2012，95，： | 1 |
| 5 | Promotion of bone formation using highly pure porous b-TCP combined with messenchymal stem cells显示文摘 | Dong J Uemura T Shirasaki Y | 2002 | Biomaterials2002，23，23： | 1 |
| 6 | Involvement of calmodulin in neuronal cell death显示文摘 | Shirasaki Y Kanazawa Y Morishima Y | 2006 | Brain Res2006，1083，1： | 1 |
| 7 | Compact optical isolator for fibers using birefringent wedges 显示文摘 | Shirasaki M Asama K | 1982 | Applied Optics1982，21，： | 1 |
| 8 | Zinc oxide varistor made from powders prepared by amine processing显示文摘 | Hishita S Yao Y Shirasaki S | 1989 | J Am Cerm Soc1989，72，2： | 1 |
| 9 | Ets transcription factors cooperate with Sp1 to activate the human Tenascin-C promoter显示文摘 | SHIRASAKI F MAKHLUF HA LEROY C | 1999 | Oncogene1999，18，54： | 1 |
| 10 | Protective effects of a gluco- corticoid ondown-regulation of pulmonary IB2-adrenergic receptors in vi- vo显示文摘 | Mak JCW Nishikawa M Shirasaki H | 1995 | J Clin Invest1995，96，5： | 1 |
| 11 | Expression of substance P (NK1) receptor mRNA in human nose 显示文摘 | Shirasaki H Asakura K Narita S | 1998 | Acta Otolaryngol1998，118，5： | 1 |
| 12 | Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa显示文摘 | SHIRASAKI H 14ANAIZUMI E WATANABE K | 2002 | Clin Exp Allergy2002，32，： | 1 |
| 13 | Involvement of calmosulin in neuronal cell death显示文摘 | Shirasaki Y Kanazawa Y Moilshima Y | 2006 | Brain Res2006，1083，1： | 1 |
| 14 | Local directional cues control growth polarity of dopaminergic axons along the rostrocaudal axis显示文摘 | Nakamura S Ito Y Shirasaki R | 2000 | J Neurosci2000，20，11： | 1 |
| 15 | Serum S-100b protein as a biomarker for the assessment of neuroprotectants 显示文摘 | Shirasaki Y Edo N Sato T | 2004 | Brain res2004，1021，2： | 1 |
| 16 | Development of membrane reformer system for highly efficient hydrogen production from natural gas显示文摘 | Shirasaki Y Tsuneki T Ota Y Yasuda I | 2009 | International Journal of Hydrogen Energy2009，34，10： | 1 |
| 17 | Loss of expression of them etastasis suppressor gene KISS1 during melanoma progression and its association with LOH of chromosome 6q16 · 3-q23 显示文摘 | Shirasaki F Takata M Hatta N | 2001 | Cancer Res2001，61，20： | 1 |
| 18 | Promotion of bone formation using highly pure porous beta-TCP combined with bone marrow derived osteoprogenitor cells显示文摘 | Dong J Uemura T Shirasaki Y | 2002 | Biomaterials2002，23，： | 1 |
| 19 | Effects ofcetirizine on substance P release in patients with perennial allergic rhinitis 显示文摘 | Shirasaki H Watanabe K Kanalzumi E | 2004 | Ann Otol Rhinol Laryngol2004，113，12： | 1 |
| 20 | Zinc oxide varistors made from powers prepared by amine processing显示文摘 | S Hishita Y Yao S Shirasaki | 1989 | Joumal of the American Ceramie Society1989，72，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员